Clinical trial
A Single and Multiple Dose Escalation First-In-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Delcetravir Administered Via Inhalation in Healthy Subjects
NCT05453279 is registered in ClinicalTrials.gov with Esfam Biotech Pty Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single and Multiple Dose Escalation First-In-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Delcetravir Administered Via Inhalation in Healthy Subjects
- Lead sponsor
- Esfam Biotech Pty Ltd
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 1, 2022
- Completion date
- January 1, 2023
- Enrollment
- 8 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.